<DOC>
	<DOC>NCT00276510</DOC>
	<brief_summary>The purpose of this study is to determine whether Tanakan® is effective at slowing the progression from memory complaint to dementia of Alzheimer's type.</brief_summary>
	<brief_title>A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Spontaneously reporting a memory complaint Short anxiety battery test &lt; 6, (only if patient screened at GP site) Geriatric depression scale &lt; 15 Minimental state (MMS) &gt; 25 in GP's office (in hospital site MMS is done as complementary scale) Objective memory impairment Clinician rated dementia staging system &gt; 0.5 Minimental state &lt; 25 Dementia, past history of seizures, Parkinson disease</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>